Offer a different choice
Make room for patients who want to discuss a non-drug device option. Different shapes, contact areas and controls let the conversation start with individual needs and preferences.
Telehealth partnerships
Virtual care.A practical connection.
Bring a physical device option into your sexual- and pelvic-health service. MV Health combines six home-use designs, published research and patient resources—so your team can build an offer around the people you care for.
For digital-health platforms, virtual clinics and pharmacy-led services.Explore MV Health devices
More ways to support your patients
A device option. A broader conversation.
Add a tangible product to your service without building a device business from scratch. Start with one patient group and a clearly defined offer.
Support use beyond the visit
Give patients something practical to take into their home routine: the right device information, setup guidance and a clear support route. Keep follow-up connected to your care plan.
Build a commercial fit
Explore referral or product-supply arrangements alongside your existing service. Agree pricing, patient costs and responsibilities before launch, with a model that works for your team.
Choose your starting point
Three routes to discuss.
The right structure depends on who recommends, sells, fulfils and supports the device. We can start with a focused pilot and scope the arrangement together.
01 / Referral route
Recommend & refer
Introduce patients to relevant device information and agree a purchasing route. A useful starting point for a service that wants to keep product sales separate from clinical consultations.
Scope together: patient journey, referral terms, disclosures and the hand-off for product questions.
02 / Product supply
Add devices to your offer
Discuss wholesale supply for your store, pharmacy or care package. Review the exact models, expected volumes and patient-facing price alongside your existing offer.
Scope together: stock or direct-delivery arrangements, seller of record, shipping, returns and warranty handling.
03 / Care programme
Build a defined pathway
Bring device education into an existing clinical service, with agreed eligibility, patient guidance and review points. Start with a specific population rather than a whole-platform rollout.
Scope together: clinical ownership, approved content, staff preparation, patient support and pilot measures.
Published research, in context
Evidence your clinical team can examine.
Explore study designs, populations and original publications. Research on device use is not the same as validation of a telehealth programme.
Randomized controlled trial / 2026
Sexual & pelvic health
84participants randomized · 8 weeks
Scheduled device use with an educational handout was compared with the handout alone. The journal report found better sexual-function scores in the device group.
Single-centre, unblinded trial; 81 completed. MV Health identifies the model as Poco; the accessible abstract does not name it. The journal report updates the earlier conference report.
Controlled feasibility pilot / 2025
Poco alongside usual care
19participants analysed · 30 enrolled
A non-randomized psychosexual-service pilot explored adding Poco to usual care, including vaginal dilator therapy. Nine of ten participants in the device group rated it mostly or completely acceptable.
An acceptability and feasibility study, not a definitive efficacy trial. Attrition and the combined-care approach matter when interpreting the findings.
Preliminary journal report / 2025
Tenuto Mini & psychogenic ED
30men studied · 8 weeks
An uncontrolled preliminary study reported improved erectile-function questionnaire scores after home use of Tenuto Mini in men with psychogenic erectile dysfunction.
Published as correspondence. No control group; the principal author disclosed a consultancy relationship and devices were supplied at no cost.
From interest to implementation
Make the hand-offs simple.
Agree a small, useful first step. Build the patient experience, operational responsibilities and review criteria before expanding.
Define the fit
Choose the patient group, market and device models. Your clinical lead reviews intended use, evidence and suitability.
Prepare the journey
Map the consultation, purchase and home-use steps. Agree patient-facing copy, guides and staff training needs.
Agree delivery
Confirm commercial terms, order handling, shipping, support, returns and any data exchanged between teams.
Review the pilot
Track uptake, support requests, patient feedback and agreed outcomes. Use the findings to decide what to refine or expand.
Clear roles, from the outset
Product expertise meets your care model.
A good partnership makes it easy for patients to know what happens next—and who to contact.
MV Health
Device information & resources
- Model information and the original product guides.
- A source-linked clinical evidence library.
- Clinician videos and professional education resources.
- Product-support contacts and a scoped commercial proposal.
Your platform
The clinical relationship
- Assessment, suitability and the recommendation.
- Patient consent, clinical records and escalation.
- Follow-up and any clinically indicated outcome review.
- Your service’s clinical, privacy and billing arrangements.
For the shared workflow, agree fulfilment, customer support, any data transfer and co-branded materials in writing.
MV.Health + HealthArc
Support patients between visits.
Explore the available HealthArc program as an optional part of your care model. Agree the complete clinical, technical and commercial arrangement before enrollment; device supply and RTM remain separate decisions.
A defined monitoring team and workflow
MV.Health supplies the selected device. HealthArc supports enrollment, patient-reported check-ins, care management and documentation. Your practice retains the care plan, clinical oversight and responsibility for eligible claims.
The monitoring record comes from patient-reported check-ins and documented care-team work, not MV device telemetry. Agree accessible reporting routes, consent, response times, escalation and EMR records.
Check fit before enrollment
Review the clinical condition, eligible monitoring setup, provider scope, payer requirements and patient cost-sharing. Confirm data-sharing arrangements and the written HealthArc-practice service agreement.
An available code, device purchase or reimbursement elsewhere does not establish coverage for your patients. Monitoring is not an emergency service.
Start your partner review
The information your team needs.
Share these resources with clinical, product and operations colleagues before your first conversation.
Device information
Compare the six designs, controls and model-specific details.
Original documents
Find the devices brochure, clinical evidence PDF and product guides.
US regulatory context
Review classification, intended use and how research is presented.
RTM information
Explore the separate monitoring workflow and billing considerations.
Partner questions
Before we begin.
Straightforward answers for your clinical, commercial and operations teams.
Which telehealth services are a good starting point?
Men’s sexual-health and virtual urology services can begin with the erectile-function device range. Women’s health, menopause and pelvic-health teams can review the relevant research and model-specific information with their clinical lead. Agree the proposed use and market before choosing the programme.
Can you provide direct-to-patient delivery or co-branding?
Discuss these as part of your proposal. The delivery model, packaging, branding permissions, service levels, returns and customer-support responsibilities need to be agreed for your programme.
What are the wholesale prices, margins and minimum volumes?
Request a current quote for the exact models, market and expected volume. The economics depend on the supply route, shipping, support and any clinical service you provide. Referral arrangements are agreed separately; there is no universal partner margin or guaranteed reimbursement.
What does FDA-registered mean for our patient-facing copy?
MV Health describes its devices as FDA-registered Class II, 510(k)-exempt. Registration is not FDA approval or clearance. Use the current model-specific US documentation when preparing claims; research into other applications does not establish an additional approved indication. Review the regulatory context.
How quickly can a partnership launch?
Start by sharing your patient group, target market, preferred models, expected volume and desired timing. A realistic launch plan follows the clinical review and agreement on pricing, fulfilment, materials and support. We will scope those requirements together rather than promise a fixed launch window.
Let’s build the right fit
Bring a practical option into virtual care.
Tell us what your service is building. We can help you identify the relevant devices, research and partnership questions for your team.